Novartis Investigative Site

Hato Rey 00919

0 studies enrolling now · 2 studies all time

What they study most

Lymphoma, Follicular, Major Depressive Disorder

Studies at this site

• A Placebo- and Paroxetine-controlled Study of the Efficacy, Safety and Tolerability of Agomelatine (25 or 50 mg) in the Treatment of Major Depressive Disorder (MDD) — Completed
• Ofatumumab Bendamustine Combination Compared With Bendamustine Monotherapy in Indolent B-cell NHL Unresponsive to Rituxtherapy — Stopped early